Enterprise DTP: MRC iCASE Doctoral Training Programme

Imperial College London is offering 6 fully funded Enterprise DTP PhD Studentships to start in 2019-20, with a stipend of £18,000 p/a. As part of this support, funding is provided at the end of three years for a 6 month writing up period. Each studentship is tied to a specific Collaborative Award in Science and Engineering (CASE) project. Enterprise DTP students will benefit from additional training through the CASE commercial partner, covering areas such as ethical standards, good laboratory practice, discovery and the development process, the R&D value chain and key activities and investment decisions, and the use of appropriate specialised equipment available to the commercial partner.

Projects:

1. Unlocking the promise of DNA vaccines
2. Optimising antimicrobial prescribing through bio-sensor guided precision prescribing
3. High throughput and effective transfection of cells using innovative methods and materials
4. Potential therapeutic effects of engineered Clostridium STp products on immune activity
5. Identifying biomarkers of treatment response in gestational trophoblastic disease through quantitative proteomics analysis of patient samples
6. New age antibiotics: Bacteriocins

For instructions on how to apply and further information, please visit: www.imperial.ac.uk/medicine/study/phd-opportunities/icase-doctoral-training-programme

Applicants must ensure they meet all Imperial PhD entry requirements. All students will belong to the Graduate School, which provides a comprehensive Transferable Skills Programme.

The applications closing date is 17 June 2019.

Consistently rated amongst the world’s best universities, Imperial College London is a science-based institution with a reputation for excellence in teaching and research.

Valuing diversity and committed to equality of opportunity.